Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEA study: pharmacokinetic interaction between green tea and tamoxifen
2019-002910-37Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Oct 2019
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tamoxifen and green tea extract in breast cancer (2 arms), sponsored by Erasmus MC. Started Oct 2019; status: active.
02
Drugs
tamoxifengreen tea extract
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2019-002910-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002910-37.